DLX4 and inflammatory breast carcinoma: In the categorized cohort, 89.7% (26 out of 29) of IBC cases showed a high percentage of positive cells staining for the DLX4 protein, while a lower percentage, 40.0% (12 out of 30), of normal breast tissue cases demonstrated DLX4 expression (chi-square test, p < 0.01).